Subscribe to RSS

DOI: 10.1055/a-2738-6905
Traction-assisted endoscopic submucosal dissection of a neuroendocrine tumor in the gastric body of a patient with autoimmune gastritis
Authors
A 75-year-old woman with known autoimmune atrophic gastritis (AAG) and previous resections of millimetric neuroendocrine tumors (NETs) presented for evaluation of a newly detected 25 × 20-mm lesion on the greater curvature of the gastric body. Vitamin B12 deficiency had also been documented in the context of AAG [1] [2].
A previous esophagogastroduodenoscopy (EGDS) confirmed the presence of a 25 × 20 mm suspected NET on the greater curvature of the gastric body. The lesion was marked, and an endoscopic submucosal dissection (ESD) was performed using a J-type hook-knife (Olympus Co. Ltd, Tokyo, Japan; [Fig. 1]). Traction was achieved through a double clip-and-band technique, which allowed for precise dissection of the lesion without significant intra-procedural bleeding ([Fig. 2] a; [Video 1]). The lesion was resected en bloc, and the resection site was closed with clips to ensure hemostasis ([Fig. 2] b).




Histopathology confirmed a R0 resection of a well-differentiated NET G1 (synaptophysin+, INSM1+, and gastrin-negative), which infiltrated the submucosa. Immunohistochemistry revealed strong expression of somatostatin receptor 2A (SSTR2A, >95% membranous positivity) and weaker expression of SSTR5. The Ki-67 proliferation index was 2.9%, indicating low proliferative activity, without peritumoral lymphatic involvement.
A follow-up EGDS demonstrated a well-healed resection scar on the greater curvature with no signs of recurrence upon high-definition white light and narrow band imaging (Olympus Co. Ltd, Tokyo, Japan) evaluation. However, five new small lesions suspicious for NETs were identified in the body/fundus and deemed suitable for endoscopic resection, highlighting the propensity for multifocal NETs in AAG.
This video case underscores the feasibility of traction-assisted ESD for large gastric NETs in AAG [3] [4]. By providing stable exposure of the submucosal plane, traction can enable precise dissection and secure margin clearance while preserving muscular integrity. Such an approach may be particularly valuable in patients with chronic inflammatory conditions that predispose them to multiple or recurrent gastric lesions [5].
Endoscopy_UCTN_Code_TTT_1AO_2AG_3AD
E-Videos is an open access online section of the journal Endoscopy, reporting on interesting cases and new techniques in gastroenterological endoscopy.
All papers include a high-quality video and are published with a Creative Commons
CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission
process. We grant 100% waivers to articles whose corresponding authors are based in
Group A countries and 50% waivers to those who are based in Group B countries as classified
by Research4Life (see: https://www.research4life.org/access/eligibility/).
This section has its own submission website at https://mc.manuscriptcentral.com/e-videos.
Conflict of Interest
The authors declare that they have no conflict of interest.
-
References
- 1 Lamberti G, Panzuto F, Pavel M. et al. Gastric neuroendocrine neoplasms. Nat Rev Dis Primers 2024; 10: 1-17
- 2 Rindi G, Mete O, Uccella S. et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 2022; 33: 115-154
- 3 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy 2022; 54: 591-622
- 4 Panzuto F, Parodi MC, Esposito G. et al. Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED). Dig Liver Dis 2024; 56: 589-600
- 5 Noh JH, Kim DH, Yoon H. et al. Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor. J Gastrointest Surg 2021; 25: 2495-2502
Correspondence
Publication History
Article published online:
19 November 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Lamberti G, Panzuto F, Pavel M. et al. Gastric neuroendocrine neoplasms. Nat Rev Dis Primers 2024; 10: 1-17
- 2 Rindi G, Mete O, Uccella S. et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol 2022; 33: 115-154
- 3 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy 2022; 54: 591-622
- 4 Panzuto F, Parodi MC, Esposito G. et al. Endoscopic management of gastric, duodenal and rectal NETs: Position paper from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Society of Gastroenterology (SIGE), Italian Society of Digestive Endoscopy (SIED). Dig Liver Dis 2024; 56: 589-600
- 5 Noh JH, Kim DH, Yoon H. et al. Clinical Outcomes of Endoscopic Treatment for Type 1 Gastric Neuroendocrine Tumor. J Gastrointest Surg 2021; 25: 2495-2502




